Clinical trial · Interventional
Are Doctors Familiar With the Test Characteristics of Lung Cancer Screening?
NCT02542332CI-TRIAL-00019055completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates whether doctors are familiar with the statistical background of lung cancer screening.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Information About the Knowledge on the Statistical Background of Lung Cancer Screening of Doctors | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| With Data | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- With Data
- description
- Participants received statistical data about lung cancer screening
- interventionNames
- Other: With Data
- type
- NO_INTERVENTION
- label
- Without Data
- description
- Participants had no statistical data on lung cancer screening
Primary outcomes (1)
- measure
- Between-groups difference in the estimated reduction of mortality due to lung cancer screening
- timeFrame
- 14 days
- description
- Participants had 14 days to complete the survey
Secondary outcomes (6)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Doctors, who were in training or had a completed specialization training in: * Pneumonology * Internal Medicine * Surgery * or Radiology Exclusion Criteria: * Doctors, with a specialized training in * ENT * Pediatrics * Pathology and doctors who had no e-mail address were excluded.
References
Publications (16)
- BACKGROUNDCouraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, Besse B, Brouchet L, Castelnau O, Frappe P, Ferretti GR, Guittet L, Khalil A, Lefebure P, Laurent F, Liebart S, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Tredaniel J, Lemarie E, Zalcman G, Barlesi F, Milleron B; French lung cancer screening statement taskforce; groupe d'Oncologie de langue francaise. From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF). Ann Oncol. 2013 Mar;24(3):586-97. doi: 10.1093/annonc/mds476. Epub 2012 Nov 7. PMID 23136229
- BACKGROUNDDupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. 1990 Apr;11(2):116-28. doi: 10.1016/0197-2456(90)90005-m. PMID 2161310
- BACKGROUNDGigerenzer G, Mata J, Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst. 2009 Sep 2;101(17):1216-20. doi: 10.1093/jnci/djp237. Epub 2009 Aug 11. PMID 19671770
- BACKGROUNDHerth FJ, Hoffmann H, Heussel CP, Biederer J, Groschel A. [Lung cancer screening--update 2014]. Pneumologie. 2014 Dec;68(12):781-3. doi: 10.1055/s-0034-1390899. Epub 2014 Dec 9. No abstract available. German. PMID 25489865
- BACKGROUNDHoffrage U, Gigerenzer G. Using natural frequencies to improve diagnostic inferences. Acad Med. 1998 May;73(5):538-40. doi: 10.1097/00001888-199805000-00024. PMID 9609869
- BACKGROUNDHoreweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, de Koning HJ. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1.